A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year. The ...

Something unusual is happening in Pokémon GO. Trainers have reported a number of new Pokémon appearing as wild spawns in ...